Rottendorf Pharma Selects ValGenesis for Validation Lifecycle Management

• Rottendorf Pharma, a CDMO based in Germany, has selected ValGenesis VLMS to digitalise its validation lifecycle management.

• The choice aims to streamline and standardise validation processes with ValGenesis’ advanced software solution.

Rottendorf Pharma, a contract development and manufacturing organisation (CDMO) based in Germany, has chosen ValGenesis VLMS for its validation lifecycle management system (VLMS).

Rottendorf Pharma specialises in the development, manufacturing, and packaging of oral solid dosage forms. The company serves pharmaceutical and biotechnology firms by providing comprehensive formulation and analytical services. The adoption of ValGenesis VLMS 5.0 is intended to enhance process efficiency through a more standardised and digital approach.

According to Markus Krellmann, Head of Validation at Rottendorf Pharma, the selection of ValGenesis was based on a thorough evaluation of two software providers. He noted, “The software’s advanced technology and clear roadmap for future innovation ensure that it will continue to deliver value and support our growth.”

Steve Reynolds, Chief Revenue Officer at ValGenesis, commented, “Rottendorf Pharma’s selection of our digital validation platform aligns perfectly with their commitment to both quality and rapid drug delivery. This partnership exemplifies ValGenesis’ dedication to supporting the advanced needs of the CDMO industry.”